Related references
Note: Only part of the references are listed.Therapeutic Approaches for Shankopathies
Xiaoming Wang et al.
DEVELOPMENTAL NEUROBIOLOGY (2014)
Epigenetic dysregulation of SHANK3 in brain tissues from individuals with autism spectrum disorders
Li Zhu et al.
HUMAN MOLECULAR GENETICS (2014)
Identification of two novel Shank3 transcripts in the developing mouse neocortex
Chikako Waga et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Detection of Clinically Relevant Genetic Variants in Autism Spectrum Disorder by Whole-Genome Sequencing
Yong-hui Jiang et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2013)
Loss of Predominant Shank3 Isoforms Results in Hippocampus-Dependent Impairments in Behavior and Synaptic Transmission
Mehreen Kouser et al.
JOURNAL OF NEUROSCIENCE (2013)
Modeling Autism by SHANK Gene Mutations in Mice
Yong-hui Jiang et al.
NEURON (2013)
Parsing Heterogeneity in Autism Spectrum Disorders: Visual Scanning of Dynamic Social Scenes in School-Aged Children
Katherine Rice et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2012)
Patterns and rates of exonic de novo mutations in autism spectrum disorders
Benjamin M. Neale et al.
NATURE (2012)
De novo mutations revealed by whole-exome sequencing are strongly associated with autism
Stephan J. Sanders et al.
NATURE (2012)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
De Novo Gene Disruptions in Children on the Autistic Spectrum
Ivan Iossifov et al.
NEURON (2012)
Genetic and Functional Analyses of SHANK2 Mutations Suggest a Multiple Hit Model of Autism Spectrum Disorders
Claire S. Leblond et al.
PLOS GENETICS (2012)
Excess of De Novo Deleterious Mutations in Genes Associated with Glutamatergic Systems in Nonsyndromic Intellectual Disability
Fadi F. Hamdan et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2011)
Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders
Christian P. Schaaf et al.
HUMAN MOLECULAR GENETICS (2011)
Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3
Xiaoming Wang et al.
HUMAN MOLECULAR GENETICS (2011)
Importance of Shank3 Protein in Regulating Metabotropic Glutamate Receptor 5 (mGluR5) Expression and Signaling at Synapses
Chiara Verpelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Shank3 mutant mice display autistic-like behaviours and striatal dysfunction
Joao Peca et al.
NATURE (2011)
Novel variants of the SHANK3 gene in Japanese autistic patients with severe delayed speech development
Chikako Waga et al.
PSYCHIATRIC GENETICS (2011)
Postsynaptic ProSAP/Shank scaffolds in the cross-hair of synaptopathies
Andreas M. Grabrucker et al.
TRENDS IN CELL BIOLOGY (2011)
Conserved role of intragenic DNA methylation in regulating alternative promoters
Alika K. Maunakea et al.
NATURE (2010)
De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia
Julie Gauthier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Targeting the correct HDAC(s) to treat cognitive disorders
Andre Fischer et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication
Ozlem Bozdagi et al.
MOLECULAR AUTISM (2010)
Neuronal cell depolarization induces intragenic chromatin modifications affecting NCAM alternative splicing
Ignacio E. Schor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system
Steven W. Flavell et al.
ANNUAL REVIEW OF NEUROSCIENCE (2008)
Involvement of the role of Chk1 in lithium-induced G2/M phase cell cycle arrest in hepatocellular carcinoma cells
Xiao-Ming Wang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Advances in autism genetics: on the threshold of a new neurobiology
Brett S. Abrahams et al.
NATURE REVIEWS GENETICS (2008)
Contribution of SHANK3 mutations to autism spectrum disorder
Rainald Moessner et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
DNA methylation regulates tissue-specific expression of Shank3
Silvana Beri et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Mouse and rat BDNF gene structure and expression revisited
Tamara Aid et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders
Christelle M. Durand et al.
NATURE GENETICS (2007)
Direct interaction of post-synaptic density-95/Dlg/ZO-1 domain-containing synaptic molecule Shank3 with GluR1 α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor
S Uchino et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms
HL Wilson et al.
JOURNAL OF MEDICAL GENETICS (2003)
Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system
MD Ehlers
NATURE NEUROSCIENCE (2003)
Synaptic scaffolding proteins in rat brain -: Ankyrin repeats of the multidomain Shank protein family interact with the cytoskeletal protein α-fodrin
TM Böckers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Sharpin, a novel postsynaptic density protein that directly interacts with the Shank family of proteins
S Lim et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2001)
Share Paper
